Advanced Solid Tumors

Oncology·MeSH: Neoplasms
151 drugs in development·65 companies·60 clinical trials

Drug Pipeline by Phase

Phase 3(23)
DrugCompany
azd3470ASTRAZENECA PLC (AZN)
AZD5069ASTRAZENECA PLC (AZN)
AZD9150ASTRAZENECA PLC (AZN)
cemiplimab+fianlimab fixed dose combinationREGENERON PHARMACEUTICALS, INC. (REGN)
chemotherapyBeOne Medicines Ltd. (ONC)
ChemotherapyBeOne Medicines Ltd. (ONC)
elironrasibREVOLUTION MEDICINES, INC. (RVMD)
fdc fianlimab+cemiplimabREGENERON PHARMACEUTICALS, INC. (REGN)
inca00186Incyte Corp. (INCY)
incb081776Incyte Corp. (INCY)
incb106385Incyte Corp. (INCY)
incmga00012Incyte Corp. (INCY)
IV RilvegostomigASTRAZENECA PLC (AZN)
LY3537982ELI LILLY & Co (LLY)
MEDI4736ASTRAZENECA PLC (AZN)
MK-3120Merck & Co., Inc. (MRK)
mRNA-4359Moderna, Inc. (MRNA)
regn15505+cemiplimabREGENERON PHARMACEUTICALS, INC. (REGN)
SC RilvegostomigASTRAZENECA PLC (AZN)
SC rilvegostomig + rHuASTRAZENECA PLC (AZN)
tebentafuspImmunocore Holdings plc (IMCR)
tsr-042TESARO, Inc. (TSRO)
zoldonrasibREVOLUTION MEDICINES, INC. (RVMD)
Phase 2(22)
DrugCompany
ACR-2316Acrivon Therapeutics, Inc. (ACRV)
agen2373AGENUS INC (AGEN)
alks 4230Mural Oncology plc (MURA)
BMS-986249CytomX Therapeutics, Inc. (CTMX)
BMS-986288CytomX Therapeutics, Inc. (CTMX)
Calcium folinateBRISTOL MYERS SQUIBB CO (BMY)
capmatinibNovartis AG (NVS)
capmatinibNovartis AG (NVS)
CediranibMerus N.V. (MRUS)
CediranibADMA BIOLOGICS, INC. (ADMA)
EOS-448iTeos Therapeutics, Inc. (ITOS)
incb099280Incyte Corp. (INCY)
incb099318Incyte Corp. (INCY)
Interleukin-2Filana Therapeutics Inc. (FLNA)
LEE011Novartis AG (NVS)
navicixizumabOncoMed Pharmaceuticals Inc (OMED)
nazartinibNovartis AG (NVS)
nuzefatide pevedotinBICYCLE THERAPEUTICS PLC (BCYC)
osimertinibNovartis AG (NVS)
rtx-224Rubius Therapeutics, Inc. (RUBY)
rtx-240Rubius Therapeutics, Inc. (RUBY)
solnerstotugSensei Biotherapeutics, Inc. (SNSE)
Phase 1(68)
DrugCompany
AB521EXELIXIS, INC. (EXEL)
ABBV-181AbbVie Inc. (ABBV)
ABBV-368AbbVie Inc. (ABBV)
AbirateroneBioNTech SE (BNTX)
adagrasibIncyte Corp. (INCY)
amg 355AMGEN INC (AMGN)
amg 436AMGEN INC (AMGN)
Anti-PD-1 monoclonal antibodyiTeos Therapeutics, Inc. (ITOS)
Anticancer agentiTeos Therapeutics, Inc. (ITOS)
APR-1051Aprea Therapeutics, Inc. (APRE)
ASP1570IGM Biosciences, Inc. (IGMS)
ATRN-119Aprea Therapeutics, Inc. (APRE)
bg-c477BeOne Medicines Ltd. (ONC)
BG-C477BeOne Medicines Ltd. (ONC)
BG-C477Merus N.V. (MRUS)
bgm-2121PRECISION BIOSCIENCES INC (DTIL)
blu-222Blueprint Medicines Corp (BPMC)
brenetafuspImmunocore Holdings plc (IMCR)
Brenetafusp and chemotherapyImmunocore Holdings plc (IMCR)
Brenetafusp and kinase inhibitorsImmunocore Holdings plc (IMCR)
Brenetafusp and monoclonal antibodies and chemotherapyImmunocore Holdings plc (IMCR)
Brenetafusp and tebentafuspImmunocore Holdings plc (IMCR)
cemiplimabREGENERON PHARMACEUTICALS, INC. (REGN)
CLN-418Cullinan Therapeutics, Inc. (CGEM)
CLN-619Cullinan Therapeutics, Inc. (CGEM)
CX-904CytomX Therapeutics, Inc. (CTMX)
DB-1311KYNTRA BIO INC. (KYNB)
Efbalropendekin alfa (XmAb306 / RG6323)Xencor Inc (XNCR)
elzovantinibTurning Point Therapeutics, Inc. (TPTX)
EnzalutamideBioNTech SE (BNTX)
EOS006215iTeos Therapeutics, Inc. (ITOS)
EOS301984iTeos Therapeutics, Inc. (ITOS)
felezonexorSTEMLINE THERAPEUTICS INC (STML)
FID-022Fulgent Genetics Inc. (FLGT)
gen1079Genmab A/S (GMAB)
gs-2121GILEAD SCIENCES, INC. (GILD)
IMC-R117C (PIWIL-1)Immunocore Holdings plc (IMCR)
Interleukin-2Merus N.V. (MRUS)
itraconazoleKYNTRA BIO INC. (KYNB)
KSQ-001EXENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EXENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EXMerus N.V. (MRUS)
KSQ-004EXFilana Therapeutics Inc. (FLNA)
Lopinavir and Ritonavir TabletsBioNTech SE (BNTX)
loxo-292LOXO ONCOLOGY, INC. (LOXO)
MGC028MACROGENICS INC (MGNX)
mnpr-101-luMonopar Therapeutics (MNPR)
mnpr-101-zrMonopar Therapeutics (MNPR)
NT-I7Merck & Co., Inc. (MRK)
NUV-868KYNTRA BIO INC. (KYNB)
panitumumabAMGEN INC (AMGN)
promitilRafael Holdings, Inc. (RFL)
pt-112SCICLONE PHARMACEUTICALS INC (SCLN)
qtx3544QUANTA INC (QNTA)
Recombinant Human HyaluronidaseASTRAZENECA PLC (AZN)
RP-6306IGM Biosciences, Inc. (IGMS)
sim0505NextCure, Inc. (NXTC)
sl-801STEMLINE THERAPEUTICS INC (STML)
sqz-pbmc-hpvSQZ Biotechnologies Co (SQZB)
tcrt-eso-a2Athenex, Inc. (ATNX)
tev-56278Teva Pharmaceutical Industries Limited (TEVA)
TilsotolimodAbbVie Inc. (ABBV)
tpx-0046Turning Point Therapeutics, Inc. (TPTX)
Trifluridine + TipiracilIGM Biosciences, Inc. (IGMS)
tsr-022TESARO, Inc. (TSRO)
XmAb808Xencor Inc (XNCR)
ZimberelimabArcus Biosciences, Inc. (RCUS)
zw191Zymeworks Inc. (ZYME)
Phase 1/Phase 2(25)
DrugCompany
anti pd-1/l1AMGEN INC (AMGN)
cemiplimabVERTEX PHARMACEUTICALS INC / MA (VRTX)
cetuximabAC Immune SA (ACIU)
cetuximabREVOLUTION MEDICINES, INC. (RVMD)
envometinibImmuneering Corp (IMRX)
gen1079GENMAB A/S (GNMSF)
imc-r117cImmunocore Holdings plc (IMCR)
ItraconazoleBioNTech SE (BNTX)
ivonescimabREVOLUTION MEDICINES, INC. (RVMD)
lee011Novartis AG (NVS)
mfolfox6AC Immune SA (ACIU)
miransertibARQULE INC (ARQL)
monalizumabAC Immune SA (ACIU)
oral repotrectinibTurning Point Therapeutics, Inc. (TPTX)
oral repotrectinibTG THERAPEUTICS, INC. (TGTX)
phase 1bASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
platinum-based doublet chemotherapyREGENERON PHARMACEUTICALS, INC. (REGN)
platinum-based doublet chemotherapyVERTEX PHARMACEUTICALS INC / MA (VRTX)
REC-617RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075REGENERON PHARMACEUTICALS, INC. (REGN)
regn7075VERTEX PHARMACEUTICALS INC / MA (VRTX)
sqz-eapc-hpvSQZ Biotechnologies Co (SQZB)
trifluridine-tipiracilVERTEX PHARMACEUTICALS INC / MA (VRTX)
trifluridine-tipiracilREGENERON PHARMACEUTICALS, INC. (REGN)
XmAb662Xencor Inc (XNCR)

Compare drugs

azd3470 vs AZD5069azd3470 vs AZD9150azd3470 vs cemiplimab+fianlimab fixed dose combination

Frequently asked questions

How many drugs are in development for Advanced Solid Tumors?

BioSniper tracks 151 drugs in development for Advanced Solid Tumors across 65 companies.

How many clinical trials target Advanced Solid Tumors?

There are 60 clinical trials targeting Advanced Solid Tumors tracked by BioSniper.

Deep-dive into Advanced Solid Tumors

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis